Search research articles
Contact Us
Filters
Showing results (381-390 of 420) with videos related to
Page
of 42
Sort By:
Journal of Chemotherapy (Florence, Italy)
|
November 24, 2012
ZAAPS Program results for 2010: an activity and spectrum analysis of linezolid using clinical isolates from 75 medical centres in 24 countries
Robert K Flamm, David J Farrell, Rodrigo E Mendes, et al.
Diagnostic Microbiology and Infectious Disease
|
June 19, 2012
LEADER surveillance program results for 2010: an activity and spectrum analysis of linezolid using 6801 clinical isolates from the United States (61 medical centers)
Robert K Flamm, David J Farrell, Rodrigo E Mendes, et al.
Diagnostic Microbiology and Infectious Disease
|
March 1, 2015
Surrogate analysis of vancomycin to predict susceptible categorization of dalbavancin
Ronald N Jones, David J Farrell, Robert K Flamm, et al.
Diagnostic Microbiology and Infectious Disease
|
March 14, 2016
Antimicrobial activity of ceftaroline and comparator agents when tested against numerous species of coagulase-negative Staphylococcus causing infection in US hospitals
Helio S Sader, David J Farrell, Robert K Flamm, et al.
Diagnostic Microbiology and Infectious Disease
|
September 10, 2016
Telavancin activity tested against a collection of Staphylococcus aureus isolates causing pneumonia in hospitalized patients in the United States (2013-2014)
Leonard R Duncan, Jennifer I Smart, Robert K Flamm, et al.
International Journal of Antimicrobial Agents
|
May 29, 2007
Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004)
Douglas J Biedenbach, Jan M Bell, Helio S Sader, et al.
Antimicrobial Agents and Chemotherapy
|
January 14, 2015
In vitro spectrum of pexiganan activity when tested against pathogens from diabetic foot infections and with selected resistance mechanisms
Robert K Flamm, Paul R Rhomberg, Katie M Simpson, et al.
The Journal of Antimicrobial Chemotherapy
|
February 23, 2020
Antimicrobial activity of POL7306 tested against clinical isolates of Gram-negative bacteria collected worldwide
Helio S Sader, Paul R Rhomberg, Leonard R Duncan, et al.
Jac-Antimicrobial Resistance
|
October 24, 2025
Antimicrobial susceptibility of Enterobacterales causing infection in the elderly: focus on aztreonam-avibactam and recently approved β-lactamase inhibitor combinations
Helio S Sader, Rodrigo E Mendes, John H Kimbrough, et al.
The Journal of Antimicrobial Chemotherapy
|
April 30, 2014
Analysis of Staphylococcus aureus clinical isolates with reduced susceptibility to ceftaroline: an epidemiological and structural perspective
Richard A Alm, Robert E McLaughlin, Veronica N Kos, et al.
Page
of 42
Search research articles
Search
Showing results (381-390 of 420) with videos related to
Sort By:
Page
of 42
Journal of Chemotherapy (Florence, Italy)
|
November 24, 2012
ZAAPS Program results for 2010: an activity and spectrum analysis of linezolid using clinical isolates from 75 medical centres in 24 countries
Robert K Flamm, David J Farrell, Rodrigo E Mendes, et al.
Diagnostic Microbiology and Infectious Disease
|
June 19, 2012
LEADER surveillance program results for 2010: an activity and spectrum analysis of linezolid using 6801 clinical isolates from the United States (61 medical centers)
Robert K Flamm, David J Farrell, Rodrigo E Mendes, et al.
Diagnostic Microbiology and Infectious Disease
|
March 1, 2015
Surrogate analysis of vancomycin to predict susceptible categorization of dalbavancin
Ronald N Jones, David J Farrell, Robert K Flamm, et al.
Diagnostic Microbiology and Infectious Disease
|
March 14, 2016
Antimicrobial activity of ceftaroline and comparator agents when tested against numerous species of coagulase-negative Staphylococcus causing infection in US hospitals
Helio S Sader, David J Farrell, Robert K Flamm, et al.
Diagnostic Microbiology and Infectious Disease
|
September 10, 2016
Telavancin activity tested against a collection of Staphylococcus aureus isolates causing pneumonia in hospitalized patients in the United States (2013-2014)
Leonard R Duncan, Jennifer I Smart, Robert K Flamm, et al.
International Journal of Antimicrobial Agents
|
May 29, 2007
Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004)
Douglas J Biedenbach, Jan M Bell, Helio S Sader, et al.
Antimicrobial Agents and Chemotherapy
|
January 14, 2015
In vitro spectrum of pexiganan activity when tested against pathogens from diabetic foot infections and with selected resistance mechanisms
Robert K Flamm, Paul R Rhomberg, Katie M Simpson, et al.
The Journal of Antimicrobial Chemotherapy
|
February 23, 2020
Antimicrobial activity of POL7306 tested against clinical isolates of Gram-negative bacteria collected worldwide
Helio S Sader, Paul R Rhomberg, Leonard R Duncan, et al.
Jac-Antimicrobial Resistance
|
October 24, 2025
Antimicrobial susceptibility of Enterobacterales causing infection in the elderly: focus on aztreonam-avibactam and recently approved β-lactamase inhibitor combinations
Helio S Sader, Rodrigo E Mendes, John H Kimbrough, et al.
The Journal of Antimicrobial Chemotherapy
|
April 30, 2014
Analysis of Staphylococcus aureus clinical isolates with reduced susceptibility to ceftaroline: an epidemiological and structural perspective
Richard A Alm, Robert E McLaughlin, Veronica N Kos, et al.
Page
of 42